UK government letter agrees nicotine pouches are lower risk than smoking and a harm reduction tool

Jan.06
UK government letter agrees nicotine pouches are lower risk than smoking and a harm reduction tool
In correspondence with 20isPlenty campaigners, the government agreed nicotine pouches are likely to pose lower health risks than smoking and confirmed they are a harm reduction tool, while warning about their high nicotine content, fast absorption and potential to be flavoured.

Key Points

 

• Position: officials agree pouches are lower risk than smoking and regulation should avoid pushing adults back to cigarettes

• Warning: nicotine is addictive; high strength, fast absorption and flavouring can lead to dependence, and minors should not use them

• Campaign asks: 20mg strength cap plus strong age limits and enforcement, without blanket restrictions

• Bill status and category: pouches treated as their own category under the Tobacco and Vapes Bill; under-18 sales to be illegal

• Evidence and consultation: consultations planned on flavours/ingredients/packaging/display; further research and a “living evidence map” commissioned

 


 

2Firsts,January 6, 2026 – According to Talking Retail,in correspondence with 20isPlenty campaigners, agreed nicotine pouches are both safer than cigarettes and an effective harm reduction tool, while warning of their high nicotine content.

 

In a response letter from the Health Secretary’s offices, officials agreed that pouches present a lower risk than smoking and must be regulated in a way that avoids driving adults back to cigarettes. 

 

Campaigners said ministers should back a clear 20mg strength cap, the core goal of 20isPlenty, a collaborative campaign by harm reduction advocates We Vape, Considerate Pouchers, ecigclick, Planet of the Vapes and the Snus and Nicotine Pouch Users Alliance. The groups also called for robust age limits and protection of adult access, rather than blanket restrictions treating all nicotine as if it were smoking.

 

While the government has not agreed to the strength limit, the letter set out positions including: 

 

  • the Committee of Toxicity report that nicotine pouches may reduce risks to smokers and are a harm reduction tool; 
  • that pouches are likely to pose lower health risks than smoking because they do not involve inhaling harmful substances produced by burning tobacco such as tar and carbon monoxide; 
  • a commitment to evidence-based and proportionate public health policy; 
  • recognition that oral nicotine products, including pouches, have the potential to reduce risks to smokers when used as intended; 
  • that nicotine products, including pouches, are treated as their own category under the Tobacco and Vapes Bill;
  •  a pledge to carefully consider restrictions to avoid unintended consequences on adult smoking rates; 
  • consultations on flavours, ingredients, packaging and display; 
  • further research commissioned including a “living evidence map”; and engagement with trade bodies and the retail sector.

 

Considerate Pouchers UK director Richard Crosby said the government accepts pouches are lower risk than smoking, sit in a separate category, and that clumsy restrictions could increase adult smoking rates. He called for a 20mg cap, strict age limits and strong enforcement, welcomed consultations on flavours, and said the campaign will continue to push for a 20mg cap.

 

Crosby had written to health minister Karin Smyth seeking answers on distinct regulation, a strength cap, public health campaigns and stronger enforcement. The letter highlighted that nicotine is addictive and should not be used by minors. The Tobacco and Vapes Bill will make sales to under-18s illegal. 

 

The bill completed its committee stage in the House of Lords in November and is awaiting report stage and third reading, expected in early 2026, before Royal Assent. The letter also referenced plans for a “smoke-free generation” that will progressively ban legal tobacco sales to anyone born on or after January 1, 2009, coming into effect from 2027.

 

A Department of Health and Social Care correspondence officer wrote that pouches are likely to pose lower health risks than smoking for the reasons cited, but that high nicotine content, fast absorption and flavouring potential can lead to nicotine dependence, with young people more susceptible due to brain development, and said the government is concerned about rising use among young people, particularly young men. 

 

The officer added that the Department plans to consult on regulations as soon as possible next year and continues engaging with trade bodies and the retail sector. The letter stated research and evidence on harms and use of nicotine pouches as a cessation aid is currently limited, cited the Committee of Toxicity report, and said the Department has commissioned further research through the National Institute for Health and Care Research, including a living evidence map.

 

Image source: Talking Retail

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Philip Morris Japan (PMJ) launched Bold Ruby as a new regular color for the IQOS ILUMA i and IQOS ILUMA i ONE in Japan on September 16, 2026, priced at JPY 6,980 and JPY 3,980, respectively. Initial sales began through IQOS online and physical channels, with convenience stores and selected tobacco retailers set to follow from September 29. Bold Ruby is a regular rather than limited-edition colorway and is available for the ILUMA i and ILUMA i ONE, but not the ILUMA i PRIME. The release does not involve changes to the devices' core hardware or functions.
Sep.22
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24
Product | JT Launches Three Autumn-Limited Ploom Tobacco Sticks in Japan Across EVO, MEVIUS and CAMEL Brands
Product | JT Launches Three Autumn-Limited Ploom Tobacco Sticks in Japan Across EVO, MEVIUS and CAMEL Brands
Japan Tobacco Inc. (JT) launched three limited-edition autumn tobacco sticks for its Ploom heated tobacco devices in Japan on October 16, 2026, under the EVO, MEVIUS and CAMEL brands. All three are regular tobacco variants with seasonal packaging. Each pack contains 20 sticks, priced at ¥620, ¥590 and ¥570, respectively, including tax. The products are compatible with all Ploom devices and are sold in limited quantities exclusively through the CLUB JT online store while supplies last.
product
Oct.20
China STMA Deputy Administrator Meets KT&G COO as Heated Cigarette Rules Advance
China STMA Deputy Administrator Meets KT&G COO as Heated Cigarette Rules Advance
Wang Gongcheng, deputy administrator of China’s State Tobacco Monopoly Administration, met KT&G Chief Operating Officer Lee Sang-hak in Shanghai on September 1, according to Oriental Tobacco News. The meeting comes as China seeks public comment on a draft mandatory national standard for heated cigarettes. The report did not disclose the subjects discussed or indicate whether heated tobacco products or market access were addressed.
News
Sep.02
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives